
Bioorganic and Medicinal Chemistry Letters p. 2773 - 2778 (1999)
Update date:2022-08-02
Topics:
Chambers
Marfat
Antognoli
Cheng
Damon
Kuperman
Liston
Mebus
Pillar
Shirley
Watson
CP-199,330 (3) and CP-199,331 (4) are cysLT1 receptor antagonists that are equipotent to marketed cysLT1 receptor antagonists zafirlukast and pranlukast, show good pharmacokinetics in rats and monkeys, and are devoid of liver toxicity in monkeys as seen in CP-85,958 (1).
View Morewebsite:http://www.synchemie.com/
Contact:+86-574-87642758
Address:Room 901, Yinyi Bund Building, 132 Renmin Road
Zibo Linzi Darong Fine Chemical Co., Ltd(expird)
Contact:86-532-67773200; 15689126900
Address:Qidu town,Linzi district,Zibo city,Shandong province,China
Nanjing Raise Pharmatech Co., Ltd
website:http://www.raisechem.com
Contact:+86-25-58649566
Address:B381,No.606,Ningliu Road,Jiangbei New Area,Nanjing,Jiangsu Province,China
Suzhou Time-chem Technologies Co., Ltd.
Contact:0512-63983931/68086856
Address:No. 1326 of Binhe Road, New District, Suzhou, Jiangsu, P. R. China
Xi'an yuanfar international trade company
website:https://www.yuanfarchemical.com
Contact:86-029-88745613 ext 828
Address:Floor19th ,B Building, Oak Block,No.36 South Fenghui Road, Dev. Zone of High-Tech Ind.,Xi’an, China
Doi:10.1039/jr9410000547
(1941)Doi:10.1002/jlcr.3073
(2013)Doi:10.1039/c3tc32388a
(2014)Doi:10.1016/j.tetlet.2014.02.024
(2014)Doi:10.1134/S1070363214020170
()Doi:10.1002/cctc.201300640
(2014)